Argent Biopharma Limited has released a press release.
March quarterly activity and cashflow report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- Mgc pharma to acquire medical research company medicanl
- Investor presentation
- Mxc completes first artemic order, march qtr record revenue
- Ethics Committee Approval Granted Phase III Clinical Trial
- SwissPharmaCan AG increases initial purchase order
Later from Argent Biopharma
- Artemic submitted to health canada
- $1M order for artemic rescue from swiss pharmacan
- Further findings on artemic as anti-inflammatory agent
- Cimetra patent submitted to european ip office
- Mgc pharma 2021 clinical trials program update
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma